- Home
- TCRX vs GRWG Comparison
TCRX vs GRWG Comparison
Compare TCRX & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- GRWG
- Stock Information
- Founded
- TCRX 2018
- GRWG 2008
- Country
- TCRX United States
- GRWG United States
- Employees
- TCRX N/A
- GRWG N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- GRWG RETAIL: Building Materials
- Sector
- TCRX Health Care
- GRWG Consumer Discretionary
- Exchange
- TCRX Nasdaq
- GRWG Nasdaq
- Market Cap
- TCRX 91.7M
- GRWG 98.0M
- IPO Year
- TCRX 2021
- GRWG N/A
- Fundamental
- Price
- TCRX $1.91
- GRWG $1.51
- Analyst Decision
- TCRX Strong Buy
- GRWG Strong Buy
- Analyst Count
- TCRX 5
- GRWG 1
- Target Price
- TCRX $9.40
- GRWG $2.50
- AVG Volume (30 Days)
- TCRX 208.8K
- GRWG 1.0M
- Earning Date
- TCRX 08-12-2025
- GRWG 08-11-2025
- Dividend Yield
- TCRX N/A
- GRWG N/A
- EPS Growth
- TCRX N/A
- GRWG N/A
- EPS
- TCRX N/A
- GRWG N/A
- Revenue
- TCRX $6,961,000.00
- GRWG $164,108,000.00
- Revenue This Year
- TCRX $255.18
- GRWG N/A
- Revenue Next Year
- TCRX N/A
- GRWG N/A
- P/E Ratio
- TCRX N/A
- GRWG N/A
- Revenue Growth
- TCRX N/A
- GRWG N/A
- 52 Week Low
- TCRX $1.02
- GRWG $0.82
- 52 Week High
- TCRX $6.23
- GRWG $2.27
- Technical
- Relative Strength Index (RSI)
- TCRX 59.09
- GRWG 52.08
- Support Level
- TCRX $1.73
- GRWG $1.64
- Resistance Level
- TCRX $1.95
- GRWG $1.68
- Average True Range (ATR)
- TCRX 0.12
- GRWG 0.14
- MACD
- TCRX 0.01
- GRWG -0.03
- Stochastic Oscillator
- TCRX 84.85
- GRWG 17.02
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.